famotidine has been researched along with Coagulation, Disseminated Intravascular in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, CC | 1 |
| Ezzelarab, M | 1 |
| Shapiro, R | 1 |
| Ekser, B | 1 |
| Long, C | 1 |
| Hara, H | 1 |
| Echeverri, G | 1 |
| Torres, C | 1 |
| Watanabe, H | 1 |
| Ayares, D | 1 |
| Dorling, A | 1 |
| Cooper, DK | 1 |
1 other study available for famotidine and Coagulation, Disseminated Intravascular
| Article | Year |
|---|---|
Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation.
Topics: Animals; Antibodies, Monoclonal; Antilymphocyte Serum; CD40 Ligand; Disseminated Intravascular Coagu | 2010 |